Neogen: Fiscal Second Quarter Earnings Overview
Neogen Corp. Reports Second Quarter Financial Results
Neogen Corp., headquartered in Lansing, Michigan, announced a net loss of $15.9 million for its fiscal second quarter.
The company reported a loss of $0.07 per share. However, after adjusting for non-recurring items, earnings reached $0.10 per share.
These adjusted earnings surpassed analysts’ expectations, as the consensus from three Zacks Investment Research analysts had predicted $0.07 per share.
Neogen, a producer of medical diagnostic kits, generated $224.7 million in revenue during the quarter, outperforming the anticipated $209.7 million forecasted by analysts surveyed by Zacks.
For the full fiscal year, Neogen projects its revenue will fall between $845 million and $855 million.
Financial data provided by Zacks Investment Research and summarized by Automated Insights.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
What is Zero Knowledge Proof? How this Blockchain is Turning Every Wall Socket into a Global Trust Hub

Why Sprout Social (SPT) Shares Are Plummeting
